Literature DB >> 15098093

[Successful treatment of skin and lung sarcoidosis with fumaric acid ester].

R Gutzmer1, A Kapp, T Werfel.   

Abstract

A 61-year old female patient with cutaneous sarcoidosis was treated with fumaric acid esters (Fumaderm). After 12 months of therapy, lesions were markedly improved and treatment was discontinued. 18 months later, the cutaneous lesions recurred, angiotensin converting enzyme (ACE) serum levels were increased and a chest X-ray demonstrated pulmonary involvement. Therapy with fumaric acid esters was again started. The skin showed improvement after 2 months and completely cleared within 17 months, within 4 months ACE levels normalized, and within 10 months radiologic changes markedly resolved. This case demonstrates a possible role for fumaric acid esters not only in the treatment of cutaneous but also systemic sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098093     DOI: 10.1007/s00105-004-0728-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  Successful therapy of annular elastolytic giant cell granuloma with fumaric acid esters.

Authors:  Ralf Gutzmer; Kristine Breuer; Peter Kiehl; Alexander Kapp; Thomas Werfel
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

2.  Cutaneous sarcoidosis successfully treated with low doses of thalidomide.

Authors:  L Rousseau; M Beylot-Barry; M S Doutre; C Beylot
Journal:  Arch Dermatol       Date:  1998-08

3.  Intralesional chloroquine for the treatment of cutaneous sarcoidosis.

Authors:  J E Liedtka
Journal:  Int J Dermatol       Date:  1996-09       Impact factor: 2.736

4.  Management of treatment-resistant cutaneous sarcoidosis with radiation.

Authors:  Bart Frizzell; McLean Stith; Joseph Jenrette
Journal:  Am J Clin Oncol       Date:  2002-12       Impact factor: 2.339

Review 5.  Sarcoidosis.

Authors:  J C English; P J Patel; K E Greer
Journal:  J Am Acad Dermatol       Date:  2001-05       Impact factor: 11.527

6.  Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate.

Authors:  R de Jong; A C Bezemer; T P Zomerdijk; T van de Pouw-Kraan; T H Ottenhoff; P H Nibbering
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

7.  Cutaneous sarcoidosis successfully treated with topical tacrolimus.

Authors:  N Katoh; H Mihara; H Yasuno
Journal:  Br J Dermatol       Date:  2002-07       Impact factor: 9.302

8.  The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.

Authors:  H M Ockenfels; T Schultewolter; G Ockenfels; R Funk; M Goos
Journal:  Br J Dermatol       Date:  1998-09       Impact factor: 9.302

9.  Treatment of disseminated granuloma annulare with fumaric acid esters.

Authors:  Alexander Kreuter; Thilo Gambichler; Peter Altmeyer; Norbert H Brockmeyer
Journal:  BMC Dermatol       Date:  2002-03-19

10.  Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters.

Authors:  Ute Nowack; Thilo Gambichler; Christoph Hanefeld; Ulrike Kastner; Peter Altmeyer
Journal:  BMC Dermatol       Date:  2002-12-24
View more
  3 in total

1.  [Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy].

Authors:  D Meyersburg; M P Schön; H P Bertsch; C S Seitz
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

2.  [Cutaneous and pulmonary sarcoidosis. Successful therapy with fumaric acid esters].

Authors:  A Wolter; M Müller; B Völker; M Gehring; F Caldarone; A Kapp; T Werfel; U Raap
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

3.  [Treatment of granulomatous cheilitis with fumaric acid esters in a young woman].

Authors:  R Kleine; L Bröhl; U Amon
Journal:  Hautarzt       Date:  2011-12       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.